Cat.#: ACPP-1218
| Despition | Dopamine D2 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1257 | MC4 Receptor Blocking Peptide (AC1257) | 250 µg | inquiry |
| ACPP-1678 | Human SDCBP Protein (AC1678) | 5 µg | inquiry |
| ACPP-1805 | Human NTS Protein (AC1805) | 5 µg | inquiry |
| ACPP-1655 | Human RAB23 Protein (AC1655) | 5 µg | inquiry |
| ACPP-1171 | Recombinant Human KCNK9 Protein (Fc Tag) (AC1171) | 50 µg | inquiry |
| ACPP-1305 | Aph 1b Blocking Peptide (AC1305) | 250 µg | inquiry |
| ACPP-1211 | Beta crystallin S Blocking Peptide (AC1211) | 250 µg | inquiry |
| ACPP-1033 | Recombinant Human PTN Protein (Fc Tag) (AC1033) | 50 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
| ACPP-1079 | Dopamine Receptor D1 Blocking Peptide (AC1079) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.